1973
DOI: 10.1136/sti.49.1.54
|View full text |Cite
|
Sign up to set email alerts
|

Spectinomycin hydrochloride (Trobicin) in the treatment of gonorrhoea. Observation of resistant strains of Neisseria gonorrhoeae.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

4
14
0

Year Published

1973
1973
2012
2012

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 36 publications
(18 citation statements)
references
References 13 publications
(6 reference statements)
4
14
0
Order By: Relevance
“…However, the isolation of f8-lactamase-producing (1,4,10) and spectinomycin-resistant (11,18) strains demonstrates the ability of N. gonorrhoeae to develop resistance to therapeutic agents. Therefore, currently available antimicrobial agents should be evaluated for potential therapeutic value against gonococcal infections.…”
mentioning
confidence: 99%
“…However, the isolation of f8-lactamase-producing (1,4,10) and spectinomycin-resistant (11,18) strains demonstrates the ability of N. gonorrhoeae to develop resistance to therapeutic agents. Therefore, currently available antimicrobial agents should be evaluated for potential therapeutic value against gonococcal infections.…”
mentioning
confidence: 99%
“…We consider spectinomycin hydrochloride to be the drug of choice for the treatment of uncomplicated gonococcal infections in patients (6). Careful surveillance will have to be maintained for the appearance of highly resistant isolates in other areas.…”
Section: Discussionmentioning
confidence: 99%
“…Besides N. gonorrhoeae can rapidly develop resistance of high-level resistance by a single mutation, it was documented in the U.S., Korea and United Kingdom (Reyn, 1973;Ashford, 1981;Barry, 2009). …”
Section: Spectinomycinmentioning
confidence: 99%